Search clinical trials for: Olodaterol (BI1744CL)
Total 85 results
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveBelgium, Denmark, Germany, Hungary
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveAustria, Belgium, Canada, Germany, Russian Federation
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Germany, Netherlands, Norway
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Australia, China, Germany, New Zealand, Taiwan
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic Obstructive | AsthmaUnited States, Canada, Germany, Netherlands
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveAustria, Germany, Canada, United States, Poland, Belgium, Portugal, United Kingdom, Australia, Denmark, New Zealand
-
Boehringer IngelheimCompletedAsthmaUnited States, Austria, Germany, Hungary, Slovakia, Slovenia
-
Boehringer IngelheimCompletedAsthmaAustria, Germany, Poland, Romania, Slovakia, Slovenia
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveAustralia, Austria, Canada, France, Germany
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Canada, Finland, France, Germany, Hungary, Italy, Spain, United Kingdom
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Belgium, Canada, Denmark, Germany, Hungary, Netherlands
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Australia, Bulgaria, Canada, China, Czech Republic, Denmark, Estonia, Finland, France, Germany, Guatemala, Hungary, India, Italy, Japan, Korea, Republic of, Mexico, Netherlands, New Zealand, Portugal, Russian... and more
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Austria, Canada, Germany, Netherlands, Russian Federation, Sweden
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Australia, Austria, Belgium, Canada, Chile, Germany, Italy, New Zealand
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Austria, Belgium, Brazil, Canada, China, Colombia, Croatia, Germany, Hungary, India, Ireland, Japan, Norway, Romania, Russian Federation, Serbia, Slovakia, South Africa, Spain, Sweden, Taiwan, Turkey, United Kingdom
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveJapan
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, China, Germany, Taiwan
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
University of DundeeCompleted
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveCanada, Germany, Netherlands, Sweden
-
Fraunhofer-Institute of Toxicology and Experimental...Boehringer IngelheimCompletedChronic Obstructive Pulmonary DiseaseGermany
-
Boehringer IngelheimCompleted
-
Yonsei UniversityNot yet recruitingChronic Obstructive Pulmonary DiseaseKorea, Republic of
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Germany
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Belgium, Canada, Czech Republic, Denmark, Finland, Germany, South Africa, Spain, United Kingdom
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Verona Pharma plcCompletedCOPDUnited States, United Kingdom
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
Queen's UniversityBoehringer IngelheimCompletedChronic Obstructive Pulmonary DiseaseCanada
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, Colombia, Croatia, Czechia, Denmark, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, India, Ireland, Italy, Japan, Korea, Republic of, Latv... and more
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Australia, Austria, Canada, Germany, Greece, New Zealand, Norway, Slovakia, South Africa, Sweden
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveArgentina, Brazil, Canada, Czech Republic, Denmark, Finland, Germany, Hong Kong, India, Italy, Korea, Republic of, Malaysia, Norway, Philippines, Romania, Russian Federation, South Africa, Spain, Sweden, Thailand
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveArgentina, Brazil, Canada, Croatia, Czech Republic, Denmark, Finland, Germany, Hong Kong, India, Italy, Korea, Republic of, Malaysia, Norway, Philippines, South Africa, Spain, Sweden, Thailand, Ukraine
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveKorea, Republic of
-
Boehringer IngelheimCompleted
-
Navire Pharma Inc., a BridgeBio companyAmgenRecruitingNon Small Cell Lung Cancer | Metastatic Solid Tumor | Solid Tumor, Adult | Metastatic NSCLCSpain, Australia, France, Denmark, Greece, Italy, Netherlands
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveChina
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveGreece
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveDenmark, Austria, Finland, France, Slovenia
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
Lundquist Institute for Biomedical Innovation at...Boehringer IngelheimCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
RWTH Aachen UniversityWithdrawn